GOVX
GeoVax LabsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GOVX Profile
Geovax Labs, Inc.
A clinical-stage biotechnology company that developing immunotherapies and vaccines for cancer and infectious diseases
1900 Lake Park Drive, Suite 380, Smyrna, GA 30080
--
GeoVax Labs, Inc., was established in June 1988. The company is a clinical-stage biotechnology company that develops immunotherapies and vaccines against cancer and infectious diseases using a novel vector vaccine platform (modified vaccinia Ankara virus-like particles or "GV-MVA-VLPTM "). The company's current development plans focus on preventive and therapeutic vaccines against human immunodeficiency virus (HIV); preventive vaccines against hemorrhagic fever virus (Ebola, Sudan, Marburg and Lhasa), Zika virus and malaria; therapeutic vaccines for chronic hepatitis B virus infection and immunotherapy against solid tumor cancer.
